Here are stories covering recent research, treatment, strategy and moves from some of the nation's top cancer hospitals:
- Researchers at Los Angeles-based City of Hope announced promising results for a new chemotherapy pill that "appears to annihilate all solid tumors."
- Roswell Park Comprehensive Cancer Center in Buffalo, N.Y., is seeking out a public relations firm to help boost its diversity, equity and inclusion presence and efforts after previously refusing to release a DEI report and being accused of racism.
- A $400 million inpatient surgical hospital will open July 31 at the Moffitt Cancer Center in Tampa, Fla.
- Clinicians are using robot-assisted technology to diagnose and treat lung cancer in a same-day procedure at Baptist Health Paducah (Ky.) and four other system hospitals.
- Seattle-based Fred Hutchinson Cancer Center is working to close the gap in communications between physicians and patients about their pain.
- Researchers at Boston-based Mass General Cancer Center found a treatment that reduced a rare type of brain tumor by an average of 91 percent in a clinical trial.
- Lebanon, N.H.-based Dartmouth Health has stayed ahead of the cancer drug shortages thanks in part to its supply chain strategy.
- Charlottesville, Va.-based UVA Cancer Center is offering some patients chimeric antigen receptor T-cell therapy in an outpatient setting.
- Leaders from Palo Alto, Calif.-based Stanford Medicine and the Department of Veterans Affairs Palo Alto Health Care System are looking to build a National Cancer Institute-designated joint cancer care and research center.
- Houston-based University of Texas MD Anderson Cancer Center and New Orleans-based Ochsner Health are partnering to create an integrated cancer program in Louisiana.
- Columbus-based Ohio State University Comprehensive Cancer Center-James researchers are preparing to launch a first-of-its-kind cancer clinical trial for a "smart drug" over telehealth.